Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy

Background: Prediction of tumor shrinkage and pattern of treatment response following neoadjuvant endocrine therapy (NET) for estrogen receptor positive (ER+), Her2 negative (Her2–) breast cancers have had limited assessment. We examined if ultrasound (US) and Ki–67 could predict the pathologic resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Liebscher, Sean C., Kilgore, Lyndsey J., Winblad, Onalisa, Gloyeske, Nika, Larson, Kelsey, Balanoff, Christa, Nye, Lauren, O’Dea, Anne, Sharma, Priyanka, Kimler, Bruce, Khan, Qamar, Wagner, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913996/
https://www.ncbi.nlm.nih.gov/pubmed/36766992
http://dx.doi.org/10.3390/healthcare11030417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913996/
https://www.ncbi.nlm.nih.gov/pubmed/36766992
http://dx.doi.org/10.3390/healthcare11030417

Ejemplares similares